Evidence map›Paper›PMID 36364180›Full record

ArticleMolecules (Basel, Switzerland)2022

Direct Furfural Production from Deciduous Wood Pentosans Using Different Phosphorus-Containing Catalysts in the Context of Biorefining.

Prans Brazdausks, Daniela Godina, Maris Puke

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Prans BrazdausksLatvian State Institute of Wood Chemistry, Dzerbenes 27, LV-1006 Riga, Latvia.
Daniela GodinaLatvian State Institute of Wood Chemistry, Dzerbenes 27, LV-1006 Riga, Latvia.
Maris PukeLatvian State Institute of Wood Chemistry, Dzerbenes 27, LV-1006 Riga, Latvia.ORCID 0000-0003-1830-6326

Funding

The European Regional Development Fund 1.1.1.2./VIAA/3/19/457
6 · The paper itself

Abstract

This study seeks to improve the effectiveness of the pretreatment stage when direct furfural production is integrated into the concept of a lignocellulosic biomass biorefinery. First of all, the catalytic effects of different phosphorus-containing salts (AlPO₄, Ca₃(PO₄)₂, FePO₄, H₃PO₄, NaH₂PO₄) were analysed in hydrolysis for their ability to convert birch wood C-5 carbohydrates into furfural. The hydrolysis process was performed with three different amounts of catalyst (2, 3 and 4 wt.%) at a constant temperature (175 °C) and treatment time (90 min). It was found that the highest amount of furfural (63-72%, calculated based on the theoretically possible yield (% t.p.y.)) was obtained when H₃PO₄ was used as a catalyst. The best furfural yield among the used phosphorus-containing salts was obtained with NaH₂PO₄: 40 ± 2%. The greatest impact on cellulose degradation during the hydrolysis process was observed using H₃PO₄ at 12-20% of the initial amount, while the lowest degradation was observed using NaH₂PO₄ as a catalyst. The yield of furfural was 60.5-62.7% t.p.y. when H₃PO₄ and NaH₂PO₄ were combined (1:2, 1:1, or 2:1 at a catalyst amount of 3 wt.%); however, the amount of cellulose that was degraded did not exceed 5.2-0.3% of the starting amount. Enzymatic hydrolysis showed that such pretreated biomass could be directly used as a substrate to produce glucose. The highest conversion ratio of cellulose into glucose (83.1%) was obtained at an enzyme load of 1000 and treatment time of 48 h.

Indexed as

FuraldehydeWoodBiomassCelluloseGlucoseHydrolysisPhosphorusSaltsCelluloseFuraldehydeGlucosePhosphorusSaltsbiorefiningenzymatic hydrolysisfurfuralhydrolysislignocellulose sourcesphosphorus-containing catalysts

Identifiers

PMID36364180
PMCPMC9658606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.